RxDoctor Payments Data
★ My doctorsLook up a doctor →

Irwin Blau

Neurology · New Hyde Park, NYNPI 1801869730

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.9% of the total across 654 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 52 manufacturers reported payments, led by AbbVie at 25.0% of the total. Reporting peaked in 2021 at $3,098 and has fallen 85.6% since, to $446 in 2025.

$10,902in general payments, 2019–2025

Across 654 payments — averaging $16.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Medtronic$1K
  • SK Life Science, Inc.$689
  • Amgen$664
  • Sanofi$560
  • UCB, Inc.$437
  • plus $4K from 46 others

What the payments were for

  • Speaking & faculty fees$140%
  • Food & beverage$10,888100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)214$2,723
Medtronic12$1,488
SK Life Science, Inc.53$689
Amgen(2 entities)27$664
Sanofi31$560
UCB, Inc.28$437
Biogen33$394
Neurocrine Biosciences, Inc.19$371
Novartis23$307
MDD US Operations, LLC19$252
AstraZeneca(2 entities)14$237
Biohaven Pharmaceutical Holding Company Ltd.19$231
Mallinckrodt Hospital Products Inc.13$191
Lundbeck LLC24$185
Teva Pharmaceuticals USA, Inc.10$164
Mallinckrodt Enterprises LLC7$157
Lilly USA, LLC10$131
Grifols USA, LLC7$130
Pfizer6$121
Corium, LLC8$98
Acadia Pharmaceuticals Inc7$91
Supernus Pharmaceuticals, Inc.5$77
Biohaven Pharmaceuticals, Inc.4$71
Upsher-smith Laboratories LLC4$70
Takeda Pharmaceuticals U.S.A., Inc.4$70
Boston Scientific4$69
GE HealthCare4$68
Avanir Pharmaceuticals, Inc.3$67
Argenx US, Inc.3$66
EMD Serono, Inc.3$65
CSL Behring3$65
Vertical Pharmaceuticals, LLC3$58
Assertio Therapeutics, Inc.4$57
Bausch Health US, LLC3$43
Abbott2$42
Amneal Pharmaceuticals LLC2$41
Eisai Inc.2$39
Zogenix Inc.2$38
Genentech USA, Inc.2$38
Neurelis, Inc.1$26
Impel Pharmaceuticals Inc.1$23
Sumitomo Pharma America, Inc.1$23
Tanabe Pharma America, Inc.1$22
Almatica Pharma LLC1$20
Avion Pharmaceuticals1$19
Adamas Pharmaceuticals, Inc.1$16
Currax Pharmaceuticals LLC1$16
Johnson & Johnson1$15
E.r. Squibb & Sons, L.L.C.1$14
Octapharma USA, Inc.1$14
Acorda Therapeutics, Inc1$14
Arbor Pharmaceuticals, Inc.1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,902 in reported general payments places this provider in the 75th percentile of 1,623 neurology providers in New York.

See all neurology providers in New York →

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin11$5,839
Dexlansoprazole DrDexlansoprazole12$1,343
Metoprolol Succinate32$167
Ramipril20$108
Atorvastatin Calcium16$72
Spironolactone11$33

Paid to pharmacies, not to this prescriber.

Other neurology in New Hyde Park

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →